Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic Sclerosis
Clinical trial NCT04166552 · SUSPENDED
Trial details
- NCT number
- NCT04166552
- Sponsor
- Emerald Health Pharmaceuticals
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-11
- Primary completion
- 2024-07-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.